- Home
- TNGX vs ODC Comparison
TNGX vs ODC Comparison
Compare TNGX & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ODC
- Stock Information
- Founded
- TNGX 2014
- ODC 1941
- Country
- TNGX United States
- ODC United States
- Employees
- TNGX N/A
- ODC N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ODC Miscellaneous manufacturing industries
- Sector
- TNGX Health Care
- ODC Consumer Discretionary
- Exchange
- TNGX Nasdaq
- ODC Nasdaq
- Market Cap
- TNGX 351.2M
- ODC 853.6M
- IPO Year
- TNGX N/A
- ODC N/A
- Fundamental
- Price
- TNGX $5.63
- ODC $60.33
- Analyst Decision
- TNGX Strong Buy
- ODC
- Analyst Count
- TNGX 6
- ODC 0
- Target Price
- TNGX $12.20
- ODC N/A
- AVG Volume (30 Days)
- TNGX 3.3M
- ODC 81.7K
- Earning Date
- TNGX 08-06-2025
- ODC 06-05-2025
- Dividend Yield
- TNGX N/A
- ODC 1.19%
- EPS Growth
- TNGX N/A
- ODC 17.38
- EPS
- TNGX N/A
- ODC 3.40
- Revenue
- TNGX $40,990,000.00
- ODC $474,062,000.00
- Revenue This Year
- TNGX N/A
- ODC N/A
- Revenue Next Year
- TNGX N/A
- ODC N/A
- P/E Ratio
- TNGX N/A
- ODC $17.76
- Revenue Growth
- TNGX 10.09
- ODC 9.92
- 52 Week Low
- TNGX $1.03
- ODC $29.47
- 52 Week High
- TNGX $12.02
- ODC $60.70
- Technical
- Relative Strength Index (RSI)
- TNGX 78.55
- ODC 68.88
- Support Level
- TNGX $4.80
- ODC $56.28
- Resistance Level
- TNGX $5.96
- ODC $60.70
- Average True Range (ATR)
- TNGX 0.51
- ODC 1.89
- MACD
- TNGX -0.02
- ODC -0.08
- Stochastic Oscillator
- TNGX 92.95
- ODC 93.07
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.